2 results
Approved WMOCompleted
This is a phase I study of hydroxyurea and dose-intense temozolomide in patients with recurrent glioblastoma that are elegise for re-challenge temozolomide.Primary Objective: To determine the maximal tolerated dose and safety profile of daily…
Approved WMOCompleted
The objective of the study is to confirm that PCNSL is positive on 89Zr-rituximab PET imaging.